Dmitry Balyasny’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-198,821
Closed -$251K 3348
2025
Q4
$251K Buy
+198,821
New +$277K ﹤0.01% 2806
2025
Q2
Sell
-84,196
Closed -$140K 3212
2025
Q1
$140K Buy
84,196
+73,432
+682% +$121K ﹤0.01% 2650
2024
Q4
$15.8K Buy
+10,764
New +$16.5K ﹤0.01% 2660
2024
Q3
Sell
-35,241
Closed -$44.1K 3040
2024
Q2
$44.1K Buy
+35,241
New +$45.7K ﹤0.01% 2440
2022
Q1
Sell
-508,967
Closed -$2.45M 2743
2021
Q4
$2.45M Buy
+508,967
New +$2.06M 0.01% 1138
2021
Q2
Sell
-484,966
Closed -$2.08M 2243
2021
Q1
$2.08M Buy
+484,966
New +$2.32M 0.01% 1005
2019
Q3
Sell
-249,098
Closed -$608K 1470
2019
Q2
$608K Buy
+249,098
New +$543K ﹤0.01% 1190
2019
Q1
Sell
-116,943
Closed -$352K 1576
2018
Q4
$352K Buy
116,943
+94,701
+426% +$321K ﹤0.01% 1185
2018
Q3
$77K Buy
+22,242
New +$118K ﹤0.01% 1607
2018
Q1
Sell
-145,016
Closed -$711K 2222
2017
Q4
$711K Sell
145,016
-129,984
-47% -$754K ﹤0.01% 1432
2017
Q3
$1.89M Buy
275,000
+234,738
+583% +$1.48M 0.01% 977
2017
Q2
$265K Buy
40,262
+17,728
+79% +$124K ﹤0.01% 1335
2017
Q1
$180K Buy
+22,534
New +$190K ﹤0.01% 1491

Other funds holding OPK

Dmitry Balyasny's OPK Position: Q1 2026 in Review

Dmitry Balyasny sold out of Opko Health (OPK) in Q1 2026, closing a stake of 198,821 shares — an estimated $251K sold.

Dmitry Balyasny first reported a position in OPK in Q1 2017 and held it in 13 quarters. The position peaked at $2.45M in Q4 2021. 236 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • Dmitry Balyasny reported no remaining Opko Health position as of Q1 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 198,821 Opko Health shares in Q1 2026, an estimated $251K.
  • Dmitry Balyasny first reported a position in Opko Health in Q1 2017 and held it in 13 quarters.
  • Dmitry Balyasny's Opko Health position peaked at $2.45M in Q4 2021.
  • 236 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.